References
- Kabukvu M, Arslantas E, Ates I, Demircioglu F, Ersel F. Clinical, echocardiographic, and hemodynamic characteristics of rheumatic mitral valve stenosis and atrial fibrillation. Angiology 2005; 56(2): 159–163.
- Boyaci A, Topaloglu S, Yilmaz S et al. Regional left atrial coagulation and fibrinolytic activities in patients with mitral stenosis. Jpn Heart J 2004; 45(5): 779–788.
- Kataoka H, Yano S, Mikuriya Y. Relationship of mitral valve areato hemostatic condition in rheumatic mitral stenosis. J Cardiol 1994; 24(5): 387–395.
- Yetkin E, Erbay AR, Turhan H et al. Decreased platelet activationand endothelial dysfunction after percutaneous mitral balloon valvuloplasty. Int J Cardiol 2003; 91: 221–225.
- Chen MC, Chang HW, Juang SS, Yip HK, Wu CJ. Increased plasma levels of soluble P-selectin in rheumatic mitral stenosis. Chest 2004; 126: 54–58.
- Niuwland R, Strurk A. Platelet derived microparticles. In: Michelson AD. (ed) Platelet. Academic Press, 2002; 255–265.
- Siljander P, Carpen O, Lassila R. platelet derived microparticles associate with fibrin during thrombosis. Blood 1996; 87: 4651–4663.
- Muller I, Klocke A, Alex M et al. Intravascular tissue factor initiates coagulation via circulating microvesicles and platelets. FASEB J 2003; 17: 476–478.
- Podor Ti, Singh D, Chindemi P et al. Vimentin exposed on activated platelets and platelet microparticles localizes vitronectin and plasminogen activator inhibitor complexes on their surface. J Biol Chem 2002; 277: 7529–7539.
- Jy W, Mao WW, Horstman L, Tao J, Ahn YS. Platelet microparticles bind, activate and aggregate neutrophils in vitro. Blood Cells Mol Dis 1995; 21: 217–231.
- Barry OP, Pratico D, Savani RC, FitzGerald GA. Modulation of monocyte-endothelial cell interactions by platelet microparticles. J Clin Invest 1998; 102: 136–144.
- English D, Garcia JG, Brindley DN. Platelet-released phospholi-pids link haemostasis and angiogenesis. Cardiovasc Res 2001; 49: 588–599.
- Bernal-Mizrachi L, Jy W, Jimenez .J.J et al. High levels of circulating endothelial microparticles in patients with acute coronary syndromes. Am Heart J 2003; 145: 962–970.
- Lee YJ, Jy W, Horstman LL et al. Elevated platelet microparticles in transient ischaemic attacks, Lacunar infarcts, and multiinfarct dementias. Thromb Res 1993; 72: 295–304.
- Koga H, Sugiyama S, Kugiyama K et al. Elevated levels of remnant lipoproteins are associated with plasma platelet micro-particles in patients with type-2 diabetes mellitus without obstructive coronary artery disease. Eur Heart J2006; 27: 817–823.
- Preston RA, Jy W, Jimenez D. et al. Effects of severe hypertension on endothelial and platelet microparticles. Hypertension 2003; 41: 211–217.
- Tan KT, Tayebjee MH, Lynd C, Blann AD, Lip GY. Platelet microparticles and soluble P selectin in peripheral artery disease: relationship to extent of disease and platelet activation markers. Ann Med 2005; 37(1): 61–66.
- Choudhury A, Chung I, Blann AD, Lip GYH. Elevated platelet microparticle levels in nonvalvular atrial fibrillation. Chest 2007; 131: 809–815.
- Sahan DJ, De Maria A, Kisslo J, Weyman A. Recommendations regarding quantitation in m-mode echocardiography: results of a survery of echocardiographic measurements. Circulation 1978; 58: 1072.
- Gardin JM, Dabestani A, Takenaka K et al. Effect of imaging view and sample volume location on evaluation of mitral flow velocity by pulsed Doppler echocardiography. Am J Cardiol 1986; 57: 1335.
- Schmitz G, Rothe G, Ruf A et al. European Working Group on Clinical Cell Analysis: consensus protocol for the flow cytometric characterisation of platelet function. Thromb Haemost 1998; 79(5): 885–896.
- Minagar A, Jy W, Jimenez D. et al. Elevated plasma endothelial microparticles in multiple sclerosis. Neurology 2001; 56: 1319–1324.
- Jy W, Horstman LL, Wang F, Duncan R, Ahn YS. Platelet factor 3 in plasma fractions: its relation to microparticles size and thromboses. Thromb Res 1995; 80: 471–482.
- Pfister SL. Role of platelet microparticles in the production of thromboxane by rabbit pulmonary artery. Hypertension 2004; 43: 428–433.
- Boulanger CM, Scoazec A, Ebrahimian T et al. Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction. Circulation 2001; 104(22): 2649–2652.
- Kim HK, Song KS, Lee ES et al. Optimized flow cytometric assay for the measurement of platelet microparticles in plasma: pre-analytic and analytic considerations. Blood Coagul Fibrinol 2002; 13: 393–397.
- Peerschke EIB, Lopez JA. Platelet membranes and receptors. In: Loscalzo J, Schafer Al. (ed) Thrombosis and hemorrhage. Baltimore, MD: Williams & Wilkins, 2000; 229–260.
- Stein PD, Sabbah HN. Measured turbulence and its effect on thrombus formation. Circ Res 1974; 35: 608–616.
- Yu SK, Latour JG, Marchandise B, Bois M. Shear stress-induced changes in platelet reactivity. Thromb Haemost 1978; 40: 551–560.
- Bernstein NE, Demopoulos LA, Tunick PA, Rosenzweig BP, Kronzon I. Correlates of spontaneous echo contrast in patients with mitral stenosis and normal sinus rhythm. Am Heart J 1994; 128(2): 287–292.
- Turitto VT, Weiss Hi. Red blood cells: their dual role in the thrombus formation. Science 1980; 207: 541–543.
- Kamath S, Blann AD, Chin BS et al. A study of platelet activation in atrial fibrillation and the effects of antithrombotic therapy. Eur Heart J 2002; 23: 1788–1795.
- Choudhury A, Chung I, Blann AD, Lip GY. Platelet surface CD62P and CD63, mean platelet volume, and soluble/platelet P-selectin as indexes of platelet function in atrial fibrillation: a comparison of 'healthy control subjects' and 'disease control subjects' in sinus rhythm. J Am Coll Cardiol 2007; 49(19): 1957–1964.